Free Trial

Waters (WAT) Stock Price, News & Analysis

$285.33
-0.88 (-0.31%)
(As of 07/8/2024 ET)
Today's Range
$283.04
$287.89
50-Day Range
$282.70
$361.47
52-Week Range
$231.90
$367.21
Volume
411,874 shs
Average Volume
463,292 shs
Market Capitalization
$16.93 billion
P/E Ratio
28.00
Dividend Yield
N/A
Price Target
$301.20

Waters MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.91 Rating Score
Upside/​Downside
5.6% Upside
$301.20 Price Target
Short Interest
Healthy
5.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.66mentions of Waters in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$1.45 M Sold Last Quarter
Proj. Earnings Growth
9.87%
From $11.85 to $13.02 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.11 out of 5 stars

Medical Sector

158th out of 876 stocks

Analytical Instruments Industry

8th out of 25 stocks

WAT stock logo

About Waters Stock (NYSE:WAT)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

WAT Stock Price History

WAT Stock News Headlines

[Urgent] Hedge Funds Expect Major Crypto Moves
In the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all…
Waters (NYSE:WAT) PT Lowered to $275.00
Dr. Brent Waters Wins Fifth Test-of-Time Award
[Urgent] Hedge Funds Expect Major Crypto Moves
In the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all…
See More Headlines
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Today
7/09/2024
Next Earnings (Confirmed)
7/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
94184810
Employees
7,900
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$301.20
High Stock Price Target
$358.00
Low Stock Price Target
$250.00
Potential Upside/Downside
+5.6%
Consensus Rating
Reduce
Rating Score (0-4)
1.91
Research Coverage
11 Analysts

Profitability

Net Income
$642.23 million
Pretax Margin
23.58%

Debt

Sales & Book Value

Annual Sales
$2.96 billion
Cash Flow
$14.54 per share
Book Value
$19.45 per share

Miscellaneous

Free Float
58,834,000
Market Cap
$16.93 billion
Optionable
Optionable
Beta
0.95

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Udit Batra Ph.D. (Age 53)
    President, CEO & Director
    Comp: $1.17M
  • Mr. Amol Chaubal (Age 47)
    Senior VP & CFO
    Comp: $635.66k
  • Ms. Jianqing Y. Bennett (Age 54)
    Senior Vice President of TA Instruments Division & Waters Clinical Business Unit
    Comp: $621.09k
  • Mr. Christos Ross
    Senior VP of Global Operations & Interim Senior VP of the Waters Division
  • Caspar Tudor
    Director of Investor Relations
  • Ms. Keeley A. Aleman (Age 47)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $897.33k
  • Ms. Kristen Garvey
    Vice President of Corporate Communications
  • Mr. Patrick Conway
    Interim Vice President of Human Resources
  • Dr. Daniel Rush Ph.D.
    Senior Vice President of Strategy & Transformation
  • John Lynch
    Treasurer

WAT Stock Analysis - Frequently Asked Questions

How have WAT shares performed this year?

Waters' stock was trading at $329.23 at the beginning of the year. Since then, WAT stock has decreased by 13.3% and is now trading at $285.33.
View the best growth stocks for 2024 here
.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) released its quarterly earnings results on Tuesday, May, 7th. The medical instruments supplier reported $2.21 EPS for the quarter, topping analysts' consensus estimates of $2.10 by $0.11. The firm's quarterly revenue was down 7.0% compared to the same quarter last year.
Read the conference call transcript
.

What is Udit Batra's approval rating as Waters' CEO?

13 employees have rated Waters Chief Executive Officer Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among the company's employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Does Waters have any subsidiaries?

The following companies are subsidiaries of Waters: Andrew Alliance S.A, Andrew Alliance, Rubotherm, MPE Orbur Group Ltd. (UK), ElectroForce, Blue Reference Inc., Baehr Thermoanalyse GmbH, and more.

Who are Waters' major shareholders?

Waters' top institutional investors include Armstrong Henry H Associates Inc. (0.02%), DNB Asset Management AS (0.02%), Massmutual Trust Co. FSB ADV (0.01%) and GAMMA Investing LLC. Insiders that own company stock include Edward Conard, Michael J Berendt, Christopher A Kuebler, Mark P Vergnano, Linda Baddour, Richard H Fearon and Thomas P Salice.
View institutional ownership trends
.

How do I buy shares of Waters?

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Waters investors own include Thermo Fisher Scientific (TMO), RTX (RTX), CVS Health (CVS), Home Depot (HD), Johnson & Johnson (JNJ) and Abbott Laboratories (ABT).

This page (NYSE:WAT) was last updated on 7/9/2024 by MarketBeat.com Staff

From Our Partners